Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Automated Analyzers Market

ID: MRFR/HC/25193-HCR
128 Pages
Nidhi Mandole
Last Updated: April 06, 2026

Automated Analyzers Market Research Report By Technology (Clinical Chemistry, Immunoassay, Coagulation, Hematology, Molecular Diagnostics, Electrochemistry, Point-of-Care Testing, Others), By Sample Type (Blood, Urine, Saliva, Tissue, Other Bodily Fluids), By Application (Clinical Diagnostics, Drug Discovery, Food Safety, Environmental Monitoring, Others), By End-User (Hospitals, Laboratories, Research Institutes, Clinics, Point-of-Care Settings), By Platform (Benchtop, Floor-standing, Point-of-Care, Portable) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Automated Analyzers Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Technology (USD Billion)
  49.     4.1.1 Clinical Chemistry
  50.     4.1.2 Immunoassay
  51.     4.1.3 Coagulation
  52.     4.1.4 Hematology
  53.     4.1.5 Molecular Diagnostics
  54.     4.1.6 Electrochemistry
  55.     4.1.7 Point-of-Care Testing
  56.     4.1.8 Others
  57.   4.2 Healthcare, BY Sample Type (USD Billion)
  58.     4.2.1 Blood
  59.     4.2.2 Urine
  60.     4.2.3 Saliva
  61.     4.2.4 Tissue
  62.     4.2.5 Other Bodily Fluids
  63.   4.3 Healthcare, BY Application (USD Billion)
  64.     4.3.1 Clinical Diagnostics
  65.     4.3.2 Drug Discovery
  66.     4.3.3 Food Safety
  67.     4.3.4 Environmental Monitoring
  68.     4.3.5 Others
  69.   4.4 Healthcare, BY End-User (USD Billion)
  70.     4.4.1 Hospitals
  71.     4.4.2 Laboratories
  72.     4.4.3 Research Institutes
  73.     4.4.4 Clinics
  74.     4.4.5 Point-of-Care Settings
  75.   4.5 Healthcare, BY Platform (USD Billion)
  76.     4.5.1 Benchtop
  77.     4.5.2 Floor-standing
  78.     4.5.3 Point-of-Care
  79.     4.5.4 Portable
  80.   4.6 Healthcare, BY Region (USD Billion)
  81.     4.6.1 North America
  82.       4.6.1.1 US
  83.       4.6.1.2 Canada
  84.     4.6.2 Europe
  85.       4.6.2.1 Germany
  86.       4.6.2.2 UK
  87.       4.6.2.3 France
  88.       4.6.2.4 Russia
  89.       4.6.2.5 Italy
  90.       4.6.2.6 Spain
  91.       4.6.2.7 Rest of Europe
  92.     4.6.3 APAC
  93.       4.6.3.1 China
  94.       4.6.3.2 India
  95.       4.6.3.3 Japan
  96.       4.6.3.4 South Korea
  97.       4.6.3.5 Malaysia
  98.       4.6.3.6 Thailand
  99.       4.6.3.7 Indonesia
  100.       4.6.3.8 Rest of APAC
  101.     4.6.4 South America
  102.       4.6.4.1 Brazil
  103.       4.6.4.2 Mexico
  104.       4.6.4.3 Argentina
  105.       4.6.4.4 Rest of South America
  106.     4.6.5 MEA
  107.       4.6.5.1 GCC Countries
  108.       4.6.5.2 South Africa
  109.       4.6.5.3 Rest of MEA
  110. 5 SECTION V: COMPETITIVE ANALYSIS
  111.   5.1 Competitive Landscape
  112.     5.1.1 Overview
  113.     5.1.2 Competitive Analysis
  114.     5.1.3 Market share Analysis
  115.     5.1.4 Major Growth Strategy in the Healthcare
  116.     5.1.5 Competitive Benchmarking
  117.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  118.     5.1.7 Key developments and growth strategies
  119.       5.1.7.1 New Product Launch/Service Deployment
  120.       5.1.7.2 Merger & Acquisitions
  121.       5.1.7.3 Joint Ventures
  122.     5.1.8 Major Players Financial Matrix
  123.       5.1.8.1 Sales and Operating Income
  124.       5.1.8.2 Major Players R&D Expenditure. 2023
  125.   5.2 Company Profiles
  126.     5.2.1 Abbott Laboratories (US)
  127.       5.2.1.1 Financial Overview
  128.       5.2.1.2 Products Offered
  129.       5.2.1.3 Key Developments
  130.       5.2.1.4 SWOT Analysis
  131.       5.2.1.5 Key Strategies
  132.     5.2.2 Roche Diagnostics (CH)
  133.       5.2.2.1 Financial Overview
  134.       5.2.2.2 Products Offered
  135.       5.2.2.3 Key Developments
  136.       5.2.2.4 SWOT Analysis
  137.       5.2.2.5 Key Strategies
  138.     5.2.3 Siemens Healthineers (DE)
  139.       5.2.3.1 Financial Overview
  140.       5.2.3.2 Products Offered
  141.       5.2.3.3 Key Developments
  142.       5.2.3.4 SWOT Analysis
  143.       5.2.3.5 Key Strategies
  144.     5.2.4 Thermo Fisher Scientific (US)
  145.       5.2.4.1 Financial Overview
  146.       5.2.4.2 Products Offered
  147.       5.2.4.3 Key Developments
  148.       5.2.4.4 SWOT Analysis
  149.       5.2.4.5 Key Strategies
  150.     5.2.5 Beckman Coulter (US)
  151.       5.2.5.1 Financial Overview
  152.       5.2.5.2 Products Offered
  153.       5.2.5.3 Key Developments
  154.       5.2.5.4 SWOT Analysis
  155.       5.2.5.5 Key Strategies
  156.     5.2.6 Danaher Corporation (US)
  157.       5.2.6.1 Financial Overview
  158.       5.2.6.2 Products Offered
  159.       5.2.6.3 Key Developments
  160.       5.2.6.4 SWOT Analysis
  161.       5.2.6.5 Key Strategies
  162.     5.2.7 Sysmex Corporation (JP)
  163.       5.2.7.1 Financial Overview
  164.       5.2.7.2 Products Offered
  165.       5.2.7.3 Key Developments
  166.       5.2.7.4 SWOT Analysis
  167.       5.2.7.5 Key Strategies
  168.     5.2.8 Mindray Medical International Limited (CN)
  169.       5.2.8.1 Financial Overview
  170.       5.2.8.2 Products Offered
  171.       5.2.8.3 Key Developments
  172.       5.2.8.4 SWOT Analysis
  173.       5.2.8.5 Key Strategies
  174.     5.2.9 Horiba, Ltd. (JP)
  175.       5.2.9.1 Financial Overview
  176.       5.2.9.2 Products Offered
  177.       5.2.9.3 Key Developments
  178.       5.2.9.4 SWOT Analysis
  179.       5.2.9.5 Key Strategies
  180.   5.3 Appendix
  181.     5.3.1 References
  182.     5.3.2 Related Reports
  183. 6 LIST OF FIGURES
  184.   6.1 MARKET SYNOPSIS
  185.   6.2 NORTH AMERICA MARKET ANALYSIS
  186.   6.3 US MARKET ANALYSIS BY TECHNOLOGY
  187.   6.4 US MARKET ANALYSIS BY SAMPLE TYPE
  188.   6.5 US MARKET ANALYSIS BY APPLICATION
  189.   6.6 US MARKET ANALYSIS BY END-USER
  190.   6.7 US MARKET ANALYSIS BY PLATFORM
  191.   6.8 CANADA MARKET ANALYSIS BY TECHNOLOGY
  192.   6.9 CANADA MARKET ANALYSIS BY SAMPLE TYPE
  193.   6.10 CANADA MARKET ANALYSIS BY APPLICATION
  194.   6.11 CANADA MARKET ANALYSIS BY END-USER
  195.   6.12 CANADA MARKET ANALYSIS BY PLATFORM
  196.   6.13 EUROPE MARKET ANALYSIS
  197.   6.14 GERMANY MARKET ANALYSIS BY TECHNOLOGY
  198.   6.15 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
  199.   6.16 GERMANY MARKET ANALYSIS BY APPLICATION
  200.   6.17 GERMANY MARKET ANALYSIS BY END-USER
  201.   6.18 GERMANY MARKET ANALYSIS BY PLATFORM
  202.   6.19 UK MARKET ANALYSIS BY TECHNOLOGY
  203.   6.20 UK MARKET ANALYSIS BY SAMPLE TYPE
  204.   6.21 UK MARKET ANALYSIS BY APPLICATION
  205.   6.22 UK MARKET ANALYSIS BY END-USER
  206.   6.23 UK MARKET ANALYSIS BY PLATFORM
  207.   6.24 FRANCE MARKET ANALYSIS BY TECHNOLOGY
  208.   6.25 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
  209.   6.26 FRANCE MARKET ANALYSIS BY APPLICATION
  210.   6.27 FRANCE MARKET ANALYSIS BY END-USER
  211.   6.28 FRANCE MARKET ANALYSIS BY PLATFORM
  212.   6.29 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
  213.   6.30 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
  214.   6.31 RUSSIA MARKET ANALYSIS BY APPLICATION
  215.   6.32 RUSSIA MARKET ANALYSIS BY END-USER
  216.   6.33 RUSSIA MARKET ANALYSIS BY PLATFORM
  217.   6.34 ITALY MARKET ANALYSIS BY TECHNOLOGY
  218.   6.35 ITALY MARKET ANALYSIS BY SAMPLE TYPE
  219.   6.36 ITALY MARKET ANALYSIS BY APPLICATION
  220.   6.37 ITALY MARKET ANALYSIS BY END-USER
  221.   6.38 ITALY MARKET ANALYSIS BY PLATFORM
  222.   6.39 SPAIN MARKET ANALYSIS BY TECHNOLOGY
  223.   6.40 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
  224.   6.41 SPAIN MARKET ANALYSIS BY APPLICATION
  225.   6.42 SPAIN MARKET ANALYSIS BY END-USER
  226.   6.43 SPAIN MARKET ANALYSIS BY PLATFORM
  227.   6.44 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
  228.   6.45 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
  229.   6.46 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  230.   6.47 REST OF EUROPE MARKET ANALYSIS BY END-USER
  231.   6.48 REST OF EUROPE MARKET ANALYSIS BY PLATFORM
  232.   6.49 APAC MARKET ANALYSIS
  233.   6.50 CHINA MARKET ANALYSIS BY TECHNOLOGY
  234.   6.51 CHINA MARKET ANALYSIS BY SAMPLE TYPE
  235.   6.52 CHINA MARKET ANALYSIS BY APPLICATION
  236.   6.53 CHINA MARKET ANALYSIS BY END-USER
  237.   6.54 CHINA MARKET ANALYSIS BY PLATFORM
  238.   6.55 INDIA MARKET ANALYSIS BY TECHNOLOGY
  239.   6.56 INDIA MARKET ANALYSIS BY SAMPLE TYPE
  240.   6.57 INDIA MARKET ANALYSIS BY APPLICATION
  241.   6.58 INDIA MARKET ANALYSIS BY END-USER
  242.   6.59 INDIA MARKET ANALYSIS BY PLATFORM
  243.   6.60 JAPAN MARKET ANALYSIS BY TECHNOLOGY
  244.   6.61 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
  245.   6.62 JAPAN MARKET ANALYSIS BY APPLICATION
  246.   6.63 JAPAN MARKET ANALYSIS BY END-USER
  247.   6.64 JAPAN MARKET ANALYSIS BY PLATFORM
  248.   6.65 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
  249.   6.66 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
  250.   6.67 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  251.   6.68 SOUTH KOREA MARKET ANALYSIS BY END-USER
  252.   6.69 SOUTH KOREA MARKET ANALYSIS BY PLATFORM
  253.   6.70 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
  254.   6.71 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
  255.   6.72 MALAYSIA MARKET ANALYSIS BY APPLICATION
  256.   6.73 MALAYSIA MARKET ANALYSIS BY END-USER
  257.   6.74 MALAYSIA MARKET ANALYSIS BY PLATFORM
  258.   6.75 THAILAND MARKET ANALYSIS BY TECHNOLOGY
  259.   6.76 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
  260.   6.77 THAILAND MARKET ANALYSIS BY APPLICATION
  261.   6.78 THAILAND MARKET ANALYSIS BY END-USER
  262.   6.79 THAILAND MARKET ANALYSIS BY PLATFORM
  263.   6.80 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
  264.   6.81 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
  265.   6.82 INDONESIA MARKET ANALYSIS BY APPLICATION
  266.   6.83 INDONESIA MARKET ANALYSIS BY END-USER
  267.   6.84 INDONESIA MARKET ANALYSIS BY PLATFORM
  268.   6.85 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
  269.   6.86 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
  270.   6.87 REST OF APAC MARKET ANALYSIS BY APPLICATION
  271.   6.88 REST OF APAC MARKET ANALYSIS BY END-USER
  272.   6.89 REST OF APAC MARKET ANALYSIS BY PLATFORM
  273.   6.90 SOUTH AMERICA MARKET ANALYSIS
  274.   6.91 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
  275.   6.92 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
  276.   6.93 BRAZIL MARKET ANALYSIS BY APPLICATION
  277.   6.94 BRAZIL MARKET ANALYSIS BY END-USER
  278.   6.95 BRAZIL MARKET ANALYSIS BY PLATFORM
  279.   6.96 MEXICO MARKET ANALYSIS BY TECHNOLOGY
  280.   6.97 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
  281.   6.98 MEXICO MARKET ANALYSIS BY APPLICATION
  282.   6.99 MEXICO MARKET ANALYSIS BY END-USER
  283.   6.100 MEXICO MARKET ANALYSIS BY PLATFORM
  284.   6.101 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
  285.   6.102 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
  286.   6.103 ARGENTINA MARKET ANALYSIS BY APPLICATION
  287.   6.104 ARGENTINA MARKET ANALYSIS BY END-USER
  288.   6.105 ARGENTINA MARKET ANALYSIS BY PLATFORM
  289.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
  290.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
  291.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  292.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USER
  293.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PLATFORM
  294.   6.111 MEA MARKET ANALYSIS
  295.   6.112 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
  296.   6.113 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
  297.   6.114 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  298.   6.115 GCC COUNTRIES MARKET ANALYSIS BY END-USER
  299.   6.116 GCC COUNTRIES MARKET ANALYSIS BY PLATFORM
  300.   6.117 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
  301.   6.118 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
  302.   6.119 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  303.   6.120 SOUTH AFRICA MARKET ANALYSIS BY END-USER
  304.   6.121 SOUTH AFRICA MARKET ANALYSIS BY PLATFORM
  305.   6.122 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
  306.   6.123 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
  307.   6.124 REST OF MEA MARKET ANALYSIS BY APPLICATION
  308.   6.125 REST OF MEA MARKET ANALYSIS BY END-USER
  309.   6.126 REST OF MEA MARKET ANALYSIS BY PLATFORM
  310.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  311.   6.128 RESEARCH PROCESS OF MRFR
  312.   6.129 DRO ANALYSIS OF HEALTHCARE
  313.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  314.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  315.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  316.   6.133 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  317.   6.134 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  318.   6.135 HEALTHCARE, BY SAMPLE TYPE, 2024 (% SHARE)
  319.   6.136 HEALTHCARE, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
  320.   6.137 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  321.   6.138 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  322.   6.139 HEALTHCARE, BY END-USER, 2024 (% SHARE)
  323.   6.140 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Billion)
  324.   6.141 HEALTHCARE, BY PLATFORM, 2024 (% SHARE)
  325.   6.142 HEALTHCARE, BY PLATFORM, 2024 TO 2035 (USD Billion)
  326.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  327. 7 LIST OF TABLES
  328.   7.1 LIST OF ASSUMPTIONS
  329.     7.1.1
  330.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  331.     7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  332.     7.2.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  333.     7.2.3 BY APPLICATION, 2025-2035 (USD Billion)
  334.     7.2.4 BY END-USER, 2025-2035 (USD Billion)
  335.     7.2.5 BY PLATFORM, 2025-2035 (USD Billion)
  336.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  337.     7.3.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  338.     7.3.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  339.     7.3.3 BY APPLICATION, 2025-2035 (USD Billion)
  340.     7.3.4 BY END-USER, 2025-2035 (USD Billion)
  341.     7.3.5 BY PLATFORM, 2025-2035 (USD Billion)
  342.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  343.     7.4.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  344.     7.4.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  345.     7.4.3 BY APPLICATION, 2025-2035 (USD Billion)
  346.     7.4.4 BY END-USER, 2025-2035 (USD Billion)
  347.     7.4.5 BY PLATFORM, 2025-2035 (USD Billion)
  348.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  349.     7.5.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  350.     7.5.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  351.     7.5.3 BY APPLICATION, 2025-2035 (USD Billion)
  352.     7.5.4 BY END-USER, 2025-2035 (USD Billion)
  353.     7.5.5 BY PLATFORM, 2025-2035 (USD Billion)
  354.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  355.     7.6.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  356.     7.6.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  357.     7.6.3 BY APPLICATION, 2025-2035 (USD Billion)
  358.     7.6.4 BY END-USER, 2025-2035 (USD Billion)
  359.     7.6.5 BY PLATFORM, 2025-2035 (USD Billion)
  360.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  361.     7.7.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  362.     7.7.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  363.     7.7.3 BY APPLICATION, 2025-2035 (USD Billion)
  364.     7.7.4 BY END-USER, 2025-2035 (USD Billion)
  365.     7.7.5 BY PLATFORM, 2025-2035 (USD Billion)
  366.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  367.     7.8.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  368.     7.8.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  369.     7.8.3 BY APPLICATION, 2025-2035 (USD Billion)
  370.     7.8.4 BY END-USER, 2025-2035 (USD Billion)
  371.     7.8.5 BY PLATFORM, 2025-2035 (USD Billion)
  372.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  373.     7.9.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  374.     7.9.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  375.     7.9.3 BY APPLICATION, 2025-2035 (USD Billion)
  376.     7.9.4 BY END-USER, 2025-2035 (USD Billion)
  377.     7.9.5 BY PLATFORM, 2025-2035 (USD Billion)
  378.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  379.     7.10.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  380.     7.10.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  381.     7.10.3 BY APPLICATION, 2025-2035 (USD Billion)
  382.     7.10.4 BY END-USER, 2025-2035 (USD Billion)
  383.     7.10.5 BY PLATFORM, 2025-2035 (USD Billion)
  384.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  385.     7.11.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  386.     7.11.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  387.     7.11.3 BY APPLICATION, 2025-2035 (USD Billion)
  388.     7.11.4 BY END-USER, 2025-2035 (USD Billion)
  389.     7.11.5 BY PLATFORM, 2025-2035 (USD Billion)
  390.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  391.     7.12.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  392.     7.12.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  393.     7.12.3 BY APPLICATION, 2025-2035 (USD Billion)
  394.     7.12.4 BY END-USER, 2025-2035 (USD Billion)
  395.     7.12.5 BY PLATFORM, 2025-2035 (USD Billion)
  396.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  397.     7.13.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  398.     7.13.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  399.     7.13.3 BY APPLICATION, 2025-2035 (USD Billion)
  400.     7.13.4 BY END-USER, 2025-2035 (USD Billion)
  401.     7.13.5 BY PLATFORM, 2025-2035 (USD Billion)
  402.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  403.     7.14.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  404.     7.14.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  405.     7.14.3 BY APPLICATION, 2025-2035 (USD Billion)
  406.     7.14.4 BY END-USER, 2025-2035 (USD Billion)
  407.     7.14.5 BY PLATFORM, 2025-2035 (USD Billion)
  408.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  409.     7.15.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  410.     7.15.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  411.     7.15.3 BY APPLICATION, 2025-2035 (USD Billion)
  412.     7.15.4 BY END-USER, 2025-2035 (USD Billion)
  413.     7.15.5 BY PLATFORM, 2025-2035 (USD Billion)
  414.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  415.     7.16.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  416.     7.16.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  417.     7.16.3 BY APPLICATION, 2025-2035 (USD Billion)
  418.     7.16.4 BY END-USER, 2025-2035 (USD Billion)
  419.     7.16.5 BY PLATFORM, 2025-2035 (USD Billion)
  420.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  421.     7.17.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  422.     7.17.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  423.     7.17.3 BY APPLICATION, 2025-2035 (USD Billion)
  424.     7.17.4 BY END-USER, 2025-2035 (USD Billion)
  425.     7.17.5 BY PLATFORM, 2025-2035 (USD Billion)
  426.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  427.     7.18.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  428.     7.18.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  429.     7.18.3 BY APPLICATION, 2025-2035 (USD Billion)
  430.     7.18.4 BY END-USER, 2025-2035 (USD Billion)
  431.     7.18.5 BY PLATFORM, 2025-2035 (USD Billion)
  432.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  433.     7.19.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  434.     7.19.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  435.     7.19.3 BY APPLICATION, 2025-2035 (USD Billion)
  436.     7.19.4 BY END-USER, 2025-2035 (USD Billion)
  437.     7.19.5 BY PLATFORM, 2025-2035 (USD Billion)
  438.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  439.     7.20.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  440.     7.20.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  441.     7.20.3 BY APPLICATION, 2025-2035 (USD Billion)
  442.     7.20.4 BY END-USER, 2025-2035 (USD Billion)
  443.     7.20.5 BY PLATFORM, 2025-2035 (USD Billion)
  444.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  445.     7.21.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  446.     7.21.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  447.     7.21.3 BY APPLICATION, 2025-2035 (USD Billion)
  448.     7.21.4 BY END-USER, 2025-2035 (USD Billion)
  449.     7.21.5 BY PLATFORM, 2025-2035 (USD Billion)
  450.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  451.     7.22.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  452.     7.22.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  453.     7.22.3 BY APPLICATION, 2025-2035 (USD Billion)
  454.     7.22.4 BY END-USER, 2025-2035 (USD Billion)
  455.     7.22.5 BY PLATFORM, 2025-2035 (USD Billion)
  456.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  457.     7.23.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  458.     7.23.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  459.     7.23.3 BY APPLICATION, 2025-2035 (USD Billion)
  460.     7.23.4 BY END-USER, 2025-2035 (USD Billion)
  461.     7.23.5 BY PLATFORM, 2025-2035 (USD Billion)
  462.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  463.     7.24.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  464.     7.24.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  465.     7.24.3 BY APPLICATION, 2025-2035 (USD Billion)
  466.     7.24.4 BY END-USER, 2025-2035 (USD Billion)
  467.     7.24.5 BY PLATFORM, 2025-2035 (USD Billion)
  468.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  469.     7.25.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  470.     7.25.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  471.     7.25.3 BY APPLICATION, 2025-2035 (USD Billion)
  472.     7.25.4 BY END-USER, 2025-2035 (USD Billion)
  473.     7.25.5 BY PLATFORM, 2025-2035 (USD Billion)
  474.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  475.     7.26.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  476.     7.26.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  477.     7.26.3 BY APPLICATION, 2025-2035 (USD Billion)
  478.     7.26.4 BY END-USER, 2025-2035 (USD Billion)
  479.     7.26.5 BY PLATFORM, 2025-2035 (USD Billion)
  480.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  481.     7.27.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  482.     7.27.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  483.     7.27.3 BY APPLICATION, 2025-2035 (USD Billion)
  484.     7.27.4 BY END-USER, 2025-2035 (USD Billion)
  485.     7.27.5 BY PLATFORM, 2025-2035 (USD Billion)
  486.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  487.     7.28.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  488.     7.28.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  489.     7.28.3 BY APPLICATION, 2025-2035 (USD Billion)
  490.     7.28.4 BY END-USER, 2025-2035 (USD Billion)
  491.     7.28.5 BY PLATFORM, 2025-2035 (USD Billion)
  492.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  493.     7.29.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  494.     7.29.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  495.     7.29.3 BY APPLICATION, 2025-2035 (USD Billion)
  496.     7.29.4 BY END-USER, 2025-2035 (USD Billion)
  497.     7.29.5 BY PLATFORM, 2025-2035 (USD Billion)
  498.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  499.     7.30.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  500.     7.30.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  501.     7.30.3 BY APPLICATION, 2025-2035 (USD Billion)
  502.     7.30.4 BY END-USER, 2025-2035 (USD Billion)
  503.     7.30.5 BY PLATFORM, 2025-2035 (USD Billion)
  504.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  505.     7.31.1
  506.   7.32 ACQUISITION/PARTNERSHIP
  507.     7.32.1

Healthcare Market Segmentation

Healthcare By Technology (USD Billion, 2025-2035)

  • Clinical Chemistry
  • Immunoassay
  • Coagulation
  • Hematology
  • Molecular Diagnostics
  • Electrochemistry
  • Point-of-Care Testing
  • Others

Healthcare By Sample Type (USD Billion, 2025-2035)

  • Blood
  • Urine
  • Saliva
  • Tissue
  • Other Bodily Fluids

Healthcare By Application (USD Billion, 2025-2035)

  • Clinical Diagnostics
  • Drug Discovery
  • Food Safety
  • Environmental Monitoring
  • Others

Healthcare By End-User (USD Billion, 2025-2035)

  • Hospitals
  • Laboratories
  • Research Institutes
  • Clinics
  • Point-of-Care Settings

Healthcare By Platform (USD Billion, 2025-2035)

  • Benchtop
  • Floor-standing
  • Point-of-Care
  • Portable

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions